mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.01 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |